Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 27, 2016 08:00 ET | Source: Aduro Biotech, Inc.

Aduro Biotech Presents Encouraging Preclinical Data Showing Combination Synergy of its Immunotherapy and Checkpoint Inhibitors to Increase Antitumor Efficacy

BERKELEY, Calif., Sept. 27, 2016 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO) today highlighted two posters presented at the Second CRI-CIMT-EATI-AACR International Cancer Immunotherapy...
September 26, 2016 08:00 ET | Source: Aduro Biotech, Inc.

Aduro Biotech’s Stephen T. Isaacs Named 2016 Visionary Leader by Berkeley Chamber of Commerce

BERKELEY, Calif., Sept. 26, 2016 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO) today announced that Stephen T. Isaacs, the company’s chairman, president and CEO, will receive the Berkeley...
September 22, 2016 08:00 ET | Source: Aduro Biotech, Inc.

Aduro Biotech to Present at LEERINK Partners Roundtable Series

BERKELEY, Calif., Sept. 22, 2016 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced that Stephen T. Isaacs, chairman, president and chief executive officer of Aduro, will...
September 06, 2016 08:00 ET | Source: Aduro Biotech, Inc.

Aduro Biotech Appoints Oncology Expert and Industry Veteran Natalie Sacks, M.D. as Chief Medical Officer

BERKELEY, Calif., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO) today announced the appointment of Natalie R. Sacks, M.D., to the position of chief medical officer. “Dr....
September 01, 2016 08:00 ET | Source: Aduro Biotech, Inc.

Aduro Biotech Announces New Corporate Offices and Laboratory Space

BERKELEY, Calif., Sept. 01, 2016 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO) today announced the opening of a new corporate office and laboratory facility, which will serve as the...
August 04, 2016 08:00 ET | Source: Aduro Biotech, Inc.

Aduro Biotech to Present at Canaccord Genuity Growth Conference

BERKELEY, Calif., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced that Gregory W. Schafer, chief operating officer of Aduro, will present at the 36th Annual...
August 03, 2016 16:01 ET | Source: Aduro Biotech, Inc.

Aduro Biotech Reports Second Quarter 2016 Financial Results

BERKELEY, Calif., Aug. 03, 2016 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ:ADRO) today reported financial results for the second quarter 2016. Net income for the three months ended June 30,...
June 09, 2016 08:00 ET | Source: Aduro Biotech, Inc.

Aduro Biotech to Present at NASDAQ Investor Conference

BERKELEY, Calif., June 09, 2016 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced that Stephen T. Isaacs, chairman, president and chief executive officer of Aduro, will present...
June 04, 2016 09:00 ET | Source: Chinook Therapeutics, Inc.

Aduro Biotech Presents Encouraging Anti-Tumor Response Data From Ongoing Phase 1b Study in Malignant Pleural Mesothelioma at ASCO

BERKELEY, Calif., June 04, 2016 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO) today announced the presentation of updated data from an ongoing Phase 1b clinical trial of its immunotherapy...
May 16, 2016 08:30 ET | Source: Chinook Therapeutics, Inc.

Aduro Biotech Announces Phase 2b ECLIPSE Trial Misses Primary Endpoint in Heavily Pretreated Metastatic Pancreatic Cancer

BERKELEY, Calif., May 16, 2016 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO) today announced that the Phase 2b ECLIPSE trial did not meet the primary endpoint of an improvement in overall...